Literature DB >> 18180094

PGD-derived human embryonic stem cell lines as a powerful tool for the study of human genetic disorders.

D Ben-Yosef1, M Malcov, R Eiges.   

Abstract

Human embryonic stem (ES) cells are derived from the inner cell mass (ICM) of blastocyst embryos. They are established from spare embryos that have been obtained by in vitro fertilization (IVF) and donated for research purposes. The ICM-derived cell lines have two unique properties, they can be propagated indefinitely in culture and have the potential to develop into practically any cell type in vitro and in vivo. Human embryonic stem (hES) cells carrying specific mutations can be used as a valuable tool for studying genetic disorders in human. One favorable approach to obtain such mutant ES cell lines is their derivation from affected preimplantation genetic diagnosed (PGD) embryos. This review focuses on the importance of deriving human ES cell lines from genetically abnormal embryos, especially in cases where no good cellular and/or animal models exist.

Entities:  

Mesh:

Year:  2007        PMID: 18180094     DOI: 10.1016/j.mce.2007.11.010

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  21 in total

Review 1.  Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.

Authors:  Claudia Gundacker; Helmut Dolznig; Mario Mikula; Margit Rosner; Oliver Brandau; Markus Hengstschläger
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

2.  Female sex bias in human embryonic stem cell lines.

Authors:  Dalit Ben-Yosef; Ami Amit; Mira Malcov; Tsvia Frumkin; Ahmi Ben-Yehudah; Ido Eldar; Nava Mey-Raz; Foad Azem; Gheona Altarescu; Paul Renbaum; Rachel Beeri; Irit Varshaver; Talia Eldar-Geva; Silvina Epsztejn-Litman; Ephrat Levy-Lahad; Rachel Eiges
Journal:  Stem Cells Dev       Date:  2011-06-24       Impact factor: 3.272

Review 3.  Pluripotent stem cells in research and treatment of hemoglobinopathies.

Authors:  Natasha Arora; George Q Daley
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 4.  Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Authors:  Kelly M Haston; Steven Finkbeiner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-28       Impact factor: 13.820

5.  Erythropoietic differentiation of a human embryonic stem cell line harbouring the sickle cell anaemia mutation.

Authors:  Marina V Pryzhkova; Ann Peters; Elias T Zambidis
Journal:  Reprod Biomed Online       Date:  2010-04-24       Impact factor: 3.828

6.  Human embryonic stem cells carrying mutations for severe genetic disorders.

Authors:  Tsvia Frumkin; Mira Malcov; Michael Telias; Veronica Gold; Tamar Schwartz; Foad Azem; Ami Amit; Yuval Yaron; Dalit Ben-Yosef
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-26       Impact factor: 2.416

Review 7.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 8.  Modelling human disease with pluripotent stem cells.

Authors:  Richard Siller; Sebastian Greenhough; In-Hyun Park; Gareth J Sullivan
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

9.  Impaired function of trophoblast cells derived from translocated hESCs may explain pregnancy loss in women with balanced translocation (11;22).

Authors:  Alina Shpiz; Dalit Ben-Yosef; Yael Kalma
Journal:  J Assist Reprod Genet       Date:  2016-08-08       Impact factor: 3.412

Review 10.  Modeling neurodevelopmental disorders using human pluripotent stem cells.

Authors:  Michael Telias; Dalit Ben-Yosef
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.